Glenn Chang - Net Worth and Insider Trading

Glenn Chang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glenn Chang owns 2 companies in total, including iBio Inc (IBIO) , and Integrated Biopharma Inc (INBP) .

Click here to see the complete history of Glenn Chang’s form 4 insider trades.

Insider Ownership Summary of Glenn Chang

Ticker Comapny Transaction Date Type of Owner
IBIO iBio Inc 2010-08-16 director
INBP Integrated Biopharma Inc 2008-06-30 director

Glenn Chang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Glenn Chang Ownership Network

Ownership Network List of Glenn Chang

No Data

Ownership Network Relation of Glenn Chang


Glenn Chang Owned Company Details

What does iBio Inc do?

Who are the key executives at iBio Inc?

Glenn Chang is the director of iBio Inc. Other key executives at iBio Inc include Chief Scientific Officer Martin Brenner , Interim CFO Felipe Duran , and director & CEO and Executive Chairman Isett Thomas Francis 3rd .

iBio Inc (IBIO) Insider Trades Summary

Over the past 18 months, Glenn Chang made no insider transaction in iBio Inc (IBIO). Other recent insider transactions involving iBio Inc (IBIO) include a net sale of 88,631 shares made by Martin Brenner ,

In summary, during the past 3 months, insiders sold 0 shares of iBio Inc (IBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,432 shares of iBio Inc (IBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,432 shares.

iBio Inc (IBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

iBio Inc Insider Transactions

No Available Data

Glenn Chang Mailing Address

Above is the net worth, insider trading, and ownership report for Glenn Chang. You might contact Glenn Chang via mailing address: C/o Ibio, Inc., 9 Innovation Way, Suite 100, Newark De 19711.

Discussions on Glenn Chang

No discussions yet.